Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
May 02, 2024 08:03 ET
|
Longeveron
Longeveron to report Q1 2024 financial results on May 14, 2024.
Longeveron to Present at the Planet MicroCap Showcase
April 25, 2024 16:05 ET
|
Longeveron
Longeveron to present at investor conference - Planet MicroCap Showcase - May 1, 2024.
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
April 18, 2024 16:05 ET
|
Longeveron
Longeveron raises $11.4 million in gross proceeds from warrent exercise offering and public offering.
Longeveron Announces Closing of $5.2 Million Public Offering
April 11, 2024 17:17 ET
|
Longeveron
Longeveron announces closing of previously announced public offering, raising $5.25 million in gross proceeds.
Longeveron Announces Pricing of $5.25 Million Public Offering
April 08, 2024 14:15 ET
|
Longeveron
Longeveron prices $5.15 million public offering with certain board member and insider participation.
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
April 08, 2024 08:30 ET
|
Longeveron
CEO Letter to Shareholders. Update on overall strategy, business objectives, approach to capital allocation, and 2024 key priorities and goals.